SPIRIX

Main information

  • Trade name:
  • SPIRIX 50 mg tablet
  • Dosage:
  • 50 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • SPIRIX 50 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Spironolactone
  • Product summary:
  • Suitability for use in older adult patients Spironolactonum Suitable for older persons, with specific cautions. Reduce the dose in moderate renal insufficiency. Do not use in severe renal insufficiency. Note risk of hyperkalaemia.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 9210
  • Authorization date:
  • 01-04-2010
  • Last update:
  • 26-07-2018